Veraxa Biotech SEC Filings
NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.04+0.01 (+0.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Veraxa Biotech filing overview
This page lists 27 recent SEC filings by Veraxa Biotech (VRXA), including 8 6-K, 4 4, 4 SCHEDULE 13D, 3 424B3. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
VRXA SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 29, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 21, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 15, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 4, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 4, 2026 | 424B3 | Prospectus | View on EDGAR |
| Sep 4, 2026 | 424B3 | Prospectus | View on EDGAR |
| Aug 31, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Aug 31, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Aug 24, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 13, 2026 | SCHEDULE 13G/A | Beneficial ownership report (passive) (amendment) | View on EDGAR |
| Aug 10, 2026 | 424B5 | Prospectus | View on EDGAR |
| Aug 10, 2026 | 424B5 | Prospectus | View on EDGAR |
| Aug 5, 2026 | F-1/A | Registration statement (foreign issuer) (amendment) | View on EDGAR |
| Aug 5, 2026 | F-1/A | Registration statement (foreign issuer) (amendment) | View on EDGAR |
| Jul 31, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 31, 2026 | F-1 | Registration statement (foreign issuer) | View on EDGAR |
| Jul 31, 2026 | F-1 | Registration statement (foreign issuer) | View on EDGAR |
| Jul 27, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 27, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 18, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jun 16, 2026 | 20-F | Annual report (foreign private issuer) | View on EDGAR |
| Jun 16, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Jun 16, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Jun 15, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Jun 15, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Jun 11, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Feb 19, 2026 | 424B3 | Prospectus | View on EDGAR |